About the course
Please note: The are still some last-minute spaces available on the programme for September 2023 start. The final application deadlines are Friday 1 September for Overseas students requiring a Student Route Visa to study in the UK or Friday 8 September for Home students.
Tuberculosis (TB) is one of the leading infectious disease killers and a major cause of death globally. Multidrug-resistant TB affects half a million people annually and is a growing threat to public health and a significant obstacle to the elimination of this disease.
Our programme will provide you with a comprehensive overview of TB with an emphasis on prevention, diagnosis, and management of drug-susceptible TB. It has been developed for trainees and consultants in infection specialities and respiratory medicine; it can also be taken by TB nurses and public health workers, and practitioners with experience in Tuberculosis. Our fee structure is the same for both home students and international students.
You will get:
- a comprehensive overview of the public health aspects of TB with an emphasis on the theory, guidelines and exercises used, to practising the taught concepts
- an in-depth review of specific and challenging aspects surrounding the clinical management of TB
- the chance to develop the skills to perform research in TB.
The programme is delivered online, allowing you to study at your own pace and in your own time. It provides an excellent structured learning platform for trainees and specialists to develop your skills in this area. Leading experts deliver lectures in the field, with the same lecturer often offering tutorials one-week post release of the talk.
The Faculty of Medicine and Dentistry (Queen Mary University of London) and Barts Health have an excellent reputation in Medicine and TB, with active research and teaching programmes in each. Barts Health NHS Trust caters for a large part of east London and treats the largest number of TB patients in Western and Central Europe, seeing 10 per cent of national TB cases.